JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Friday, April 25, 2025

Putin tests experimental nasal vaccine against COVID-19

by

1247 days ago
20211124
Russian President Vladimir Putin gestures while speaking during a cabinet meeting via video conference in the Bocharov Ruchei residence in the Black Sea resort of Sochi, Russia, Wednesday, Nov. 24, 2021. (Mikhail Metzel, Sputnik, Kremlin Pool Photo via AP)

Russian President Vladimir Putin gestures while speaking during a cabinet meeting via video conference in the Bocharov Ruchei residence in the Black Sea resort of Sochi, Russia, Wednesday, Nov. 24, 2021. (Mikhail Metzel, Sputnik, Kremlin Pool Photo via AP)

By DARIA LITVI­NO­VA-As­so­ci­at­ed Press

MOSCOW (AP) — Pres­i­dent Vladimir Putin said Wednes­day he has tak­en an ex­per­i­men­tal nasal vac­cine against the coro­n­avirus, three days af­ter he re­ceived his boost­er shot.

Rus­sia is fac­ing its worst surge of in­fec­tions and deaths since the pan­dem­ic be­gan and is strug­gling to over­come wide­spread vac­cine hes­i­tan­cy.

Putin was vac­ci­nat­ed with Sput­nik V, Rus­sia’s do­mes­ti­cal­ly de­vel­oped COVID-19 vac­cine, in the spring. On Sun­day, he said he re­ceived a boost­er shot of Sput­nik Light, the one-dose ver­sion of the jab, and said he want­ed to take part in test­ing the nasal ver­sion of Sput­nik V.

De­nis Lo­gunov, deputy di­rec­tor of Rus­sia’s state-fund­ed Gama­leya Cen­ter that de­vel­oped Sput­nik V, told Putin on Sun­day the nasal vac­cine is yet to go through clin­i­cal stud­ies and is cur­rent­ly be­ing test­ed “off-la­bel most­ly” — on the cen­ter’s staff mem­bers.

In ac­cor­dance with es­tab­lished sci­en­tif­ic pro­to­cols, the vac­cine will need to go through sev­er­al tri­al phas­es, in­clud­ing those in­volv­ing thou­sands of peo­ple, to es­tab­lish that it is safe and ef­fec­tive to use.

Last month, Rus­sia’s Health Min­istry gave a reg­u­la­to­ry go-ahead to ear­ly tri­als of the nasal form of Sput­nik V among 500 vol­un­teers, but it was not im­me­di­ate­ly clear whether it has al­ready start­ed.

Putin told a gov­ern­ment meet­ing Wednes­day that “ex­act­ly six months af­ter vac­ci­na­tion my titers of pro­tec­tive (an­ti­bod­ies) have dropped, and spe­cial­ists rec­om­mend­ed the pro­ce­dure of re­vac­ci­na­tion, which I did.”

He said he didn’t ex­pe­ri­ence any un­pleas­ant ef­fects af­ter tak­ing the nasal vac­cine.

In re­cent weeks, Rus­sia has been swept by its high­est ever COVID-19 surge, with of­fi­cials reg­u­lar­ly reg­is­ter­ing record-high num­bers of new in­fec­tions and deaths.

The surge came amid low vac­ci­na­tion rates and lax pub­lic at­ti­tudes to­ward tak­ing pre­cau­tions. Few­er than 40% of Rus­sia’s near­ly 146 mil­lion peo­ple have been ful­ly vac­ci­nat­ed, even though the coun­try ap­proved a do­mes­ti­cal­ly de­vel­oped COVID-19 vac­cine months be­fore most of the world.

Rus­sians are cur­rent­ly of­fered four do­mes­ti­cal­ly de­vel­oped vac­cines, with Sput­nik V and Sput­nik Light dom­i­nat­ing the mar­ket. Da­ta on ef­fi­ca­cy of two oth­er ones, Epi­Vac­Coro­na and Co­vi­Vac, is yet to be re­leased; just like Sput­nik V, these two shots have been giv­en reg­u­la­to­ry ap­proval be­fore com­plet­ing late-stage tri­als nec­es­sary to es­tab­lish their ef­fec­tive­ness in pre­vent­ing dis­ease.

Rus­sia’s Health Min­istry is ex­pect­ed to ap­prove a ver­sion of Sput­nik V for teenagers aged 12 to 17 on Wednes­day, Deputy Prime Min­is­ter Tatyana Go­liko­va told Putin dur­ing the gov­ern­ment meet­ing.

Ac­cord­ing to the Rus­sia’s state reg­istry of clin­i­cal tri­als, the jab, which is in essence a small­er dose of Sput­nik V, was be­ing test­ed on more than 3,600 vol­un­teers. No da­ta on its ef­fi­ca­cy has been re­leased yet.

The im­mu­niza­tion dri­ve in Rus­sia has been ham­pered by wide­spread vac­cine hes­i­tan­cy. A poll re­leased by the in­de­pen­dent poll­ster Lev­a­da Cen­ter ear­li­er this month showed that 45% of Rus­sians weren’t will­ing to get do­mes­ti­cal­ly de­vel­oped shots.

In an ef­fort to boost vac­cine up­take, doc­tors from 11 Russ­ian hos­pi­tals re­leased an open let­ter Wednes­day, invit­ing those skep­ti­cal of vac­cines — and a num­ber of promi­nent pub­lic fig­ures in par­tic­u­lar who are known to air their skep­ti­cism in pub­lic — to vis­it coro­n­avirus wards and in­ten­sive care units with COVID-19 pa­tients.

“Maybe af­ter that you’ll change your mind and few­er peo­ple will be dy­ing,” the let­ter read.

Rus­sia’s state coro­n­avirus task force re­port­ed 33,558 new in­fec­tions on Wednes­day and 1,240 deaths. Go­liko­va called the dai­ly mor­tal­i­ty num­bers “dra­mat­ic,” not­ing at the same time that con­ta­gions in the coun­try have tak­en a down­ward trend.

In to­tal, the task force has re­port­ed over 9.4 mil­lion con­firmed in­fec­tions and more than 267,000 COVID-19 deaths, by far the high­est death toll in Eu­rope. Some ex­perts be­lieve the true fig­ure is even high­er.

Re­ports by Rus­sia’s sta­tis­ti­cal ser­vice, Ros­stat, that tal­ly coro­n­avirus-linked deaths retroac­tive­ly, re­veal much high­er mor­tal­i­ty. They say 462,000 peo­ple with COVID-19 died be­tween April 2020 and Sep­tem­ber of this year.

Russ­ian of­fi­cials have said the task force on­ly in­cludes deaths for which COVID-19 was the main cause, and us­es da­ta from med­ical fa­cil­i­ties. Ros­stat us­es wider cri­te­ria for count­ing virus-re­lat­ed deaths and takes its num­bers from civ­il reg­istry of­fices where reg­is­ter­ing a death is fi­nal­ized.

COVID-19


Related articles

Sponsored

Weather

PORT OF SPAIN WEATHER

Sponsored